HomeInsightsStock Comparison

Abbott India Ltd vs Coral Laboratories Ltd Stock Comparison

Abbott India Ltd vs Coral Laboratories Ltd Stock Comparison

Last Updated on: May 21, 2025

Key Highlights

  • The Latest Trading Price of Abbott India Ltd is ₹ 31160 as of 21 May 10:23.
  • The P/E Ratio of Abbott India Ltd changed from 55.4 on March 2020 to 47.7 on March 2024 . This represents a CAGR of -2.95% over 5 yearsThe P/E Ratio of Coral Laboratories Ltd changed from 4.9 on March 2020 to 8.4 on March 2024 . This represents a CAGR of 11.38% over 5 years.
  • The Market Cap of Abbott India Ltd changed from ₹ 32842 crore on March 2020 to ₹ 57260 crore on March 2024 . This represents a CAGR of 11.76% over 5 yearsThe Market Cap of Coral Laboratories Ltd changed from ₹ 34.99 crore on March 2020 to ₹ 132.59 crore on March 2024 . This represents a CAGR of 30.53% over 5 years.
  • The revenue of Abbott India Ltd for the Mar '25 is ₹ 1680 crore as compare to the Dec '24 revenue of ₹ 1686 crore. This represent the decline of -0.32% The revenue of Coral Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 25.51 crore. This represent the decline of -100%.
  • The ebitda of Abbott India Ltd for the Mar '25 is ₹ 504.56 crore as compare to the Dec '24 ebitda of ₹ 507.84 crore. This represent the decline of -0.65% The ebitda of Coral Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 8.84 crore. This represent the decline of -100%.
  • The net profit of Abbott India Ltd changed from ₹ 290.24 crore to ₹ 367.04 crore over 8 quarters. This represents a CAGR of 12.45% The net profit of Coral Laboratories Ltd changed from ₹ 1.84 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Abbott India Ltd changed from 89.6 % on March 2020 to 72.53 % on March 2024 . This represents a CAGR of -4.14% over 5 yearsThe Dividend Payout of Coral Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Abbott India Ltd

  • Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
  • The Company sells its products through independent distributors primarily within India.
  • It provides products and solutions across various therapeutic areas such as Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc.
  • Its global products include Brufen, Prothiaden, Thyronorm and Leptos. The company has four divisions.
  • The Primary Care division markets products in the areas of pain management and gastroenterology.

About Coral Laboratories Ltd

  • Coral Laboratories Limited (CLL) was established in February, 1997.
  • Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines.
  • The Company produces various pharmaceutical formulations in 3 different locations all over India.
  • It has plants at Daman and Dehradun . The Company was promoted by Navin B Doshi of the DWD group.
  • To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company went into public issue in March 94 at a total cost of Rs.2.5 crores.

Abbott India Ltd News Hub

News

Abbott India AGM scheduled

Abbott India announced that the 81th Annual General Meeting(AGM) of the company will be he...

Read more

16 May 2025 09:25

News

Board of Abbott India recommends final dividend

Abbott India announced that the Board of Directors of the Company at its meeting held on 1...

Read more

16 May 2025 09:25

News

Abbott India rises after Q4 PAT jumps 28% YoY to Rs 367 cr; declares dividend of Rs 475 /sh

Profit before tax (PBT) stood at Rs 482.71 crore in Q4 FY25, up 23.9% YoY. Total expenses ...

Read more

16 May 2025 10:58

News

Abbott India to conduct board meeting

Abbott India will hold a meeting of the Board of Directors of the Company on 15 May 2025. ...

Read more

07 May 2025 14:26

News

Abbott India appoints senior management personnel

Abbott India has appointed Anushree Kunhambu - Associate Director - New Product Introducti...

Read more

16 Apr 2025 09:38

News

Abbott India announces resignation of senior management personnel

Abbott India announced the resignation of Namita Shah - Associate Director - New Product I...

Read more

16 Apr 2025 14:57

Coral Laboratories Ltd News Hub

News

Coral Laboratories announces board meeting date

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 13 Febr...

Read more

06 Feb 2025 13:39

News

Coral Laboratories schedules board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

08 Nov 2024 17:38

News

Coral Laboratories announces board meeting date

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 24 Sept...

Read more

20 Sep 2024 10:20

News

Coral Laboratories to hold AGM

Coral Laboratories announced that the Annual General Meeting (AGM) of the company will be ...

Read more

20 Aug 2024 16:23

News

Coral Laboratories AGM scheduled

Coral Laboratories announced that the Annual General Meeting (AGM) of the company will be ...

Read more

20 Aug 2024 10:44

News

Coral Laboratories to conduct board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 14 Augu...

Read more

10 Aug 2024 12:47

SWOT Analysis Of Abbott India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Coral Laboratories Ltd

Strength

3

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Abbott India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Coral Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Abbott India Ltd and Coral Laboratories Ltd

Which company has a larger market capitalization, Abbott India Ltd or Coral Laboratories Ltd?

Market cap of Abbott India Ltd is 65,431 Cr while Market cap of Coral Laboratories Ltd is 259 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Coral Laboratories Ltd?

The stock performance of Abbott India Ltd and Coral Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Coral Laboratories Ltd?

As of May 21, 2025, the Abbott India Ltd stock price is INR ₹30791.15. On the other hand, Coral Laboratories Ltd stock price is INR ₹725.55.

How do dividend payouts of Abbott India Ltd and Coral Laboratories Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Coral Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions